Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.25USD
18 May 2018
Change (% chg)

$-0.10 (-2.30%)
Prev Close
$4.35
Open
$4.35
Day's High
$4.65
Day's Low
$4.22
Volume
16,296
Avg. Vol
5,693
52-wk High
$8.56
52-wk Low
$3.40

Chart for

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $56.33
Shares Outstanding(Mil.): 10.04
Dividend: --
Yield (%): --

Financials

  ATXI.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -0.53 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Avenue Therapeutics Reports Q4 Loss Per Share $0.63

* AVENUE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

01 Mar 2018

Earnings vs. Estimates